Challenges to HIV Prevention — Seeking Effective Measures in the Absence of a Vaccine
New England Journal of MedicinePublished 9 April 2008
Stephen W. Lagakos, Alicia R. Gable
Citations60
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
It is critical to learn how to optimize the use of multiple, partially effective biomedical and behavioral interventions in the settings and populations in which they are most effective.
Abstract
In the 15 to 20 years it may take to develop and evaluate a highly efficacious vaccine, the world may be facing 20 to 60 million new HIV infections. Stephen Lagakos and Alicia Gable write that it is critical to learn how to optimize the use of multiple, partially effective biomedical and behavioral interventions in the settings and populations in which they are most effective.
Keywords
Social SciencesMedicine
New England Journal of MedicineEffect of Herpes Simplex Suppression on Incidence of HIV among Women in Tanzania
367 Citations2008Deborah Watson‐Jones, Helen A. Weiss +14 more
Data show no evidence that acyclovir (400 mg twice daily) as HSV suppressive therapy decreases the incidence of infection with HIV.